Cabozantinib in Hepatocellular Carcinoma
NCT04588051
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
HCC
Interventions
DRUG:
Cabozantinib
Sponsor
Stephen Chan Lam